General Information of Drug Off-Target (DOT) (ID: OTJE0NOY)

DOT Name Trehalase (TREH)
Synonyms EC 3.2.1.28; Alpha,alpha-trehalase; Alpha,alpha-trehalose glucohydrolase
Gene Name TREH
Related Disease
Adult glioblastoma ( )
Advanced cancer ( )
Autosomal dominant optic atrophy, classic form ( )
Chromosomal disorder ( )
Congenital nephrotic syndrome, Finnish type ( )
Familial nephrotic syndrome ( )
Glioblastoma multiforme ( )
Glioma ( )
Hepatocellular carcinoma ( )
Herpes simplex infection ( )
Intestinal obstruction ( )
Lung cancer ( )
Lung carcinoma ( )
Medulloblastoma ( )
Neoplasm ( )
Nephropathy ( )
Non-alcoholic fatty liver disease ( )
Polyarteritis nodosa ( )
Vasculitis due to ADA2 deficiency ( )
Diarrhea-vomiting due to trehalase deficiency ( )
Non-insulin dependent diabetes ( )
Non-small-cell lung cancer ( )
UniProt ID
TREA_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
EC Number
3.2.1.28
Pfam ID
PF01204
Sequence
MPGRTWELCLLLLLGLGLGSQEALPPPCESEIYCHGELLNQVQMAKLYQDDKQFVDMPLS
IAPEQVLQTFTELSRDHNHSIPREQLQAFVHEHFQAKGQELQPWTPADWKDSPQFLQKIS
DAKLRAWAGQLHQLWKKLGKKMKPEVLSHPERFSLIYSEHPFIVPGGRFVEFYYWDSYWV
MEGLLLSEMAETVKGMLQNFLDLVKTYGHVPNGGRVYYLQRSQPPLLTLMMDCYLTHTND
TAFLQENIETLALELDFWTKNRTVSVSLEGKNYLLNRYYVPYGGPRPESYSKDVELADTL
PEGDREALWAELKAGAESGWDFSSRWLIGGPNPNSLSGIRTSKLVPVDLNAFLCQAEELM
SNFYSRLGNDSQATKYRILRSQRLAALNTVLWDEQTGAWFDYDLEKKKKNREFYPSNLTP
LWAGCFSDPGVADKALKYLEDNRILTYQYGIPTSLQKTGQQWDFPNAWAPLQDLVIRGLA
KAPLRRAQEVAFQLAQNWIRTNFDVYSQKSAMYEKYDVSNGGQPGGGGEYEVQEGFGWTN
GVVLMLLDRYGDRLTSGAKLAFLEPHCLAATLLPSLLLSLLPW
Function Intestinal trehalase is probably involved in the hydrolysis of ingested trehalose.
Tissue Specificity Expressed in kidney, liver and small intestine. Also more weakly expressed in pancreas.
KEGG Pathway
Starch and sucrose metabolism (hsa00500 )
Metabolic pathways (hsa01100 )
Reactome Pathway
Digestion of dietary carbohydrate (R-HSA-189085 )

Molecular Interaction Atlas (MIA) of This DOT

22 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Adult glioblastoma DISVP4LU Strong Genetic Variation [1]
Advanced cancer DISAT1Z9 Strong Biomarker [2]
Autosomal dominant optic atrophy, classic form DISXUAV9 Strong Altered Expression [3]
Chromosomal disorder DISM5BB5 Strong Altered Expression [4]
Congenital nephrotic syndrome, Finnish type DIS8P7EH Strong Biomarker [5]
Familial nephrotic syndrome DISADF8G Strong Altered Expression [5]
Glioblastoma multiforme DISK8246 Strong Genetic Variation [1]
Glioma DIS5RPEH Strong Genetic Variation [6]
Hepatocellular carcinoma DIS0J828 Strong Biomarker [7]
Herpes simplex infection DISL1SAV Strong Genetic Variation [8]
Intestinal obstruction DISE52WH Strong Altered Expression [4]
Lung cancer DISCM4YA Strong Altered Expression [9]
Lung carcinoma DISTR26C Strong Altered Expression [9]
Medulloblastoma DISZD2ZL Strong Biomarker [10]
Neoplasm DISZKGEW Strong Biomarker [7]
Nephropathy DISXWP4P Strong Altered Expression [4]
Non-alcoholic fatty liver disease DISDG1NL Strong Biomarker [11]
Polyarteritis nodosa DISRQ5X8 Strong Altered Expression [12]
Vasculitis due to ADA2 deficiency DIS1UHPY Strong Altered Expression [12]
Diarrhea-vomiting due to trehalase deficiency DISQXEG3 Supportive Autosomal dominant [13]
Non-insulin dependent diabetes DISK1O5Z Limited Altered Expression [14]
Non-small-cell lung cancer DIS5Y6R9 Limited Altered Expression [15]
------------------------------------------------------------------------------------
⏷ Show the Full List of 22 Disease(s)
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
3 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Acetaminophen DMUIE76 Approved Acetaminophen decreases the expression of Trehalase (TREH). [16]
Hydrocortisone DMGEMB7 Approved Hydrocortisone decreases the activity of Trehalase (TREH). [17]
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene increases the expression of Trehalase (TREH). [18]
------------------------------------------------------------------------------------

References

1 Association between RTEL1, PHLDB1, and TREH Polymorphisms and Glioblastoma Risk: A Case-Control Study.Med Sci Monit. 2015 Jul 9;21:1983-8. doi: 10.12659/MSM.893723.
2 Adeno-associated virus-mediated doxycycline-regulatable TRAIL expression suppresses growth of human breast carcinoma in nude mice.BMC Cancer. 2012 Apr 24;12:153. doi: 10.1186/1471-2407-12-153.
3 Proteasome dysfunction induces excessive proteome instability and loss of mitostasis that can be mitigated by enhancing mitochondrial fusion or autophagy.Autophagy. 2019 Oct;15(10):1757-1773. doi: 10.1080/15548627.2019.1596477. Epub 2019 Apr 19.
4 Amniotic fluid microvillar enzyme activity in fetal malformations.Clin Genet. 1990 Nov;38(5):340-5. doi: 10.1111/j.1399-0004.1990.tb03592.x.
5 Prenatal detection of the congenital nephrotic syndrome (Finnish type) by trehalase assay in amniotic fluid.Prenat Diagn. 1984 Jul-Aug;4(4):257-60. doi: 10.1002/pd.1970040404.
6 Polymorphisms of TREH, IL4R and CCDC26 genes associated with risk of glioma.Cancer Epidemiol. 2012 Jun;36(3):283-7. doi: 10.1016/j.canep.2011.12.011. Epub 2012 Feb 26.
7 Reversion of tumor hepatocytes to normal hepatocytes during liver tumor regression in an oncogene-expressing transgenic zebrafish model.Dis Model Mech. 2019 Oct 17;12(10):dmm039578. doi: 10.1242/dmm.039578.
8 Regulated Mesenchymal Stem Cells Mediated Colon Cancer Therapy Assessed by Reporter Gene Based Optical Imaging.Int J Mol Sci. 2018 Mar 27;19(4):1002. doi: 10.3390/ijms19041002.
9 An improved Tet-On regulatable FasL-adenovirus vector system for lung cancer therapy.J Mol Med (Berl). 2006 Mar;84(3):215-25. doi: 10.1007/s00109-005-0009-1. Epub 2005 Dec 31.
10 Loss of Pin1 Suppresses Hedgehog-Driven Medulloblastoma Tumorigenesis.Neoplasia. 2017 Mar;19(3):216-225. doi: 10.1016/j.neo.2017.01.002. Epub 2017 Feb 3.
11 Lactotrehalose, an Analog of Trehalose, Increases Energy Metabolism Without Promoting Clostridioides difficile Infection in Mice.Gastroenterology. 2020 Apr;158(5):1402-1416.e2. doi: 10.1053/j.gastro.2019.11.295. Epub 2019 Dec 12.
12 Induction of podocyte-derived VEGF ameliorates podocyte injury and subsequent abnormal glomerular development caused by puromycin aminonucleoside.Pediatr Res. 2011 Jul;70(1):83-9. doi: 10.1203/PDR.0b013e31821bdf1c.
13 Clinical Practice Guidelines for Rare Diseases: The Orphanet Database. PLoS One. 2017 Jan 18;12(1):e0170365. doi: 10.1371/journal.pone.0170365. eCollection 2017.
14 Identification of genetic variation that determines human trehalase activity and its association with type 2 diabetes.Hum Genet. 2013 Jun;132(6):697-707. doi: 10.1007/s00439-013-1278-3. Epub 2013 Mar 7.
15 Transition from SCLC to NSCLC phenotype is accompanied by an increased TRE-binding activity and recruitment of specific AP-1 proteins.Oncogene. 1998 Jun 11;16(23):3057-68. doi: 10.1038/sj.onc.1201845.
16 Blood transcript immune signatures distinguish a subset of people with elevated serum ALT from others given acetaminophen. Clin Pharmacol Ther. 2016 Apr;99(4):432-41.
17 Effect of hydrocortisone on the maturation of human foetal kidney explants in serum-free organ culture. Biochem Cell Biol. 1989 Feb-Mar;67(2-3):121-7. doi: 10.1139/o89-019.
18 Identification of a transcriptomic signature of food-relevant genotoxins in human HepaRG hepatocarcinoma cells. Food Chem Toxicol. 2020 Jun;140:111297. doi: 10.1016/j.fct.2020.111297. Epub 2020 Mar 28.